Instil Bio Inc TIL

Healthcare Biotechnology

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.

NDAQ:TIL - Post by User

Instil Bio Inc

Bullboard Posts

Post by kakundaon Oct 02, 2011 7:14pm

446 Views

Post# 19109775

bob 4977

we are in the same camp partner.l bought a rather large position at 1.24 for my wife.Due to the location,the managment and up coming news l thought it was a good bet.We will know by Christmas and then we will make our descion.Markets move up and down and l believe there is much more potential.Well either my wife gets the mac computer or a i phone depending on the price of the shares near Christmas.THE KAKUNDA

Bullboard Posts

Opawica seeks drill permits for Bazooka Gold Targets in Abitibi